Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Editorials
You have accessRestricted Access

Border Health: State-Level Variation in Predialysis Nephrology Care

Yoshio N. Hall and Jonathan Himmelfarb
CJASN November 2015, 10 (11) 1892-1894; DOI: https://doi.org/10.2215/CJN.09440915
Yoshio N. Hall
Kidney Research Institute, University of Washington, Seattle, Washington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Himmelfarb
Kidney Research Institute, University of Washington, Seattle, Washington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • View PDF
Loading
  • end-stage renal disease
  • United States Renal Data System
  • progression of chronic renal failure
  • ethnicity
  • clinical epidemiology
  • chronic kidney disease

For over four decades, Americans have enjoyed near universal access to treatment for ESRD irrespective of age, lack of qualifying disability, or their ability to pay. However, the health insurance benefits of the Medicare ESRD program do not extend to individuals in earlier stages of CKD, even to those for whom ESRD is imminent. Timely nephrology care before ESRD onset (predialysis nephrology care) has been linked not only to fewer biochemical abnormalities and increased use of an arteriovenous fistula or graft as initial vascular access, but more importantly, higher rates of kidney transplantation and lower rates of hospitalization and death compared with its absence (1–4). However, for many Americans, access to timely nephrology care remains elusive, particularly for members of vulnerable or traditionally underserved groups, such as racial-ethnic minorities, persons of severely limited socioeconomic means, and those who lack or churn in and out of health insurance coverage (1–3,5). Over one half of patients initiating ESRD treatment every year are estimated to belong to at least one of these underserved groups (6).

On March 23, 2010, President Barack Obama signed into law the Patient Protection and Affordable Care Act (ACA), which was enacted to increase the availability, quality, and affordability of health insurance by expanding public and private insurance coverage. Key features of the ACA include Medicaid expansion to households with incomes up to 138% of the federal poverty level, and subsidized private coverage from insurance marketplaces for households with incomes between 100% and 400% of the federal poverty level (Medicaid currently covers 70 million people in the United States at an average annual cost of $475 billion) (7). In June of 2012, the US Supreme Court upheld the constitutionality of the ACA’s individual insurance mandate while also ruling to allow states to opt out of Medicaid expansion. Before the first enrollment phase of the ACA, the nation’s 43 million uninsured nonelderly residents were equally divided between the 31 states that have (to date) adopted the expansion and the 20 states that have not (8).

In this issue of the Clinical Journal of the American Society of Nephrology (CJASN), Yan et al. (9) analyze registry data from the US Renal Data System to examine determinants of state to state variation in receipt of predialysis nephrology care (defined as nephrology care for 12 or more months before ESRD onset) among 373,986 adults who initiated ESRD treatment in the United States during 2005–2009. Leveraging patient-level data from the Centers of Medicare and Medicaid 2005 Medical Evidence Form (Form 2728-U3) on the presence and duration of nephrology care before ESRD treatment, Yan et al. (9) observed large interstate variation (10th–90th percentiles, 19%–42%) in receipt of predialysis nephrology care. Approximately one half to two thirds of this variation was attributable to state-level differences in general health care access, delivery of preventative care, and proxies of socioeconomic status. Among these indices, measures of general health care access, primarily the state’s fraction of uninsured nonelderly adults and the scope and performance of its Medicaid program, accounted for roughly one third of the total interstate variation.

The findings by Yan et al. (9) align with and extend the observations of prior reports, which have linked predialysis nephrology care with area-based proxies of health insurance penetration, socioeconomic status, and racial-ethnic composition (10–13). Moreover, this study reinforces earlier observations by Kurella-Tamura et al. (12) that states with broader Medicaid coverage had smaller insurance–related gaps in predialysis nephrology care access and lower incidence of ESRD. In a large national survey of American adults, Sommers et al. (14) recently observed significant improvements in trends for self-reported coverage, access to a personal physician and medications, and health after the ACA’s first and second open enrollment periods. Combined with the study by Yan et al. (9), these reports generate considerable optimism for timely improvements in nephrology care access for patients with advanced CKD, most importantly for those who reside in states that bear a disproportionate burden of ESRD but where relatively low levels of predialysis nephrology care were observed (e.g., California, Illinois, and Pennsylvania). However, state-level delays in health insurance expansion are clearly bad news for many patients with progressive CKD and may further disadvantage vulnerable groups residing primarily in the South, where ESRD incidence is relatively high and access to predialysis nephrology care low compared with other regions of the nation.

The study by Yan et al. (9) also highlights deficiencies in the surveillance of health care provided to nonelderly adults with CKD in the United States. On the basis of their results, approximately 70% of adults initiating ESRD treatment were not in the care of a nephrologist during the 12 months preceding ESRD onset. Access was lowest for nonelderly blacks, only one quarter of whom received nephrology care 12 months before initiating ESRD treatment. For many nonelderly United States citizens or residents, the period leading up to ESRD represents a blind spot in CKD surveillance (15). This knowledge gap is particularly large for members of traditionally underserved groups who disproportionately receive their ambulatory care from charitable or publicly funded health clinics (i.e., the health care safety net), where CKD metrics are not routinely measured or reported (16). Moreover, despite the central role of Medicaid in covering vulnerable populations, timely standardized encounter data, such as diagnoses, procedures, and measures of utilization, are largely unavailable for its enrollees (17).

Although the scope of state-level programs and socioeconomic health undoubtedly provides a platform for timely nephrology care, other factors likely play an equally important role in care access and delivery. For example, factors, such as the supply, training, and availability of health care providers, as well as physical determinants, such as the proximity and resources of health care facilities, have been associated with care access and delivery before and after ESRD onset (18–20). The study by Yan et al. (9) did not adequately assess these issues. It is unsurprising that the study’s proxies of health care resources, such as the number of primary care physicians or nephrologists per population within each state, were not associated with predialysis nephrology care (9); these measures assume equal within–state distribution (and access) and were likely too crude to yield meaningful information. Geographic properties, such as population density, similarly do not adequately capture spatial or physical barriers to care, such as travel distance or public access to health care facilities or facility–level health resources. Moreover, the study’s estimates of nephrology care were solely on the basis of patients who lived to initiate treatment for ESRD (9). Most patients with CKD die before reaching ESRD, and differences in health policy and health care access likely play similarly important roles in determining premature mortality. Lastly, the study did not address interstate variation in the uninsured case mix (9): some states may need to focus particularly on constituents who are eligible for the subsidized plans, whereas other states will need to concentrate instead on reducing the Medicaid churning that results from economic fluctuations (21).

Despite these limitations, the study by Yan et al. (9) provides timely estimates of whether and to what extent variation in state-level policy and resources might influence access to predialysis nephrology care. In the wake of the ACA implementation, the nephrology community eagerly awaits additional studies investigating area- and individual-level changes in access to and quality measures of both primary and specialty care. As evidenced by the Medicaid expansion experiment in Oregon, better access to health insurance and services may not necessarily translate into immediate improvements in health or cost savings (22). Additional programs to optimize the management of CKD risk factors among high–risk, low–income populations, such as those instituted in the 1990s by the Indian Health Service, will likely be needed to successfully translate care access into measurable, population–level declines in ESRD (23). However, realizing high–value and –quality care for low-income populations will require substantial reform and modernization of Medicaid, particularly its managed care programs, which collectively account for 70% of Medicaid beneficiaries (24). Standardizing data collection and reporting within and across state Medicaid programs will provide the foundation for identifying actionable items and sharing of promising innovations. Moreover, although we may learn much from the ACA about the effects of state-level changes in health insurance coverage on preparing patients for ESRD, we will need to encourage broader population health initiatives supported by updated, reliable data and systematic health promotion to reduce the excess morbidity, mortality, and costs associated with CKD. For the foreseeable future, states are likely to continue to vary in terms of not only nephrology care access and ESRD incidence but also, their willingness to step back from health policies that undermine their ability to achieve greater value and quality in caring for our nation’s most vulnerable constituents.

Disclosures

Y.N.H. has the following disclosures unrelated to the editorial content: member of the CJASN Editorial Board and serves as a Guest Editor for Advances in Chronic Kidney Disease. J.H. has the following disclosures unrelated to the editorial content: consultancy agreement with Biogen Idec.; ownership agreement with Thrasos Innovations, Inc.; research funding from Blood Purification Technologies, Inc.; and honoraria from Biogen Idec., Kyowa Hakko Kirin Co., Ltd., and various academic institutions for invited lectures. J.H. also serves as a scientific advisor and/or a member of the following: Journal of the American Society of Nephrology (Editorial Board); CJASN (Editorial Board); Current Opinion in Nephrology and Hypertension (Guest Editor); BMC Medicine (Editorial Board); Faculty of 1000 Medicine (Editorial Board); Faculty of 1000 Research (Editorial Board); Oxford Textbook of Clinical Nephrology, 4th Edition (Managing Editor); Decision Support Medicine, LLC (Editor); Data Monitoring Boards for the National Institutes of Health; and VA Thrasos Innovations, Inc. (Chair of Steering Committee for clinical trials).

Footnotes

  • Published online ahead of print. Publication date available at www.cjasn.org.

  • See related article, “Interstate Variation in Receipt of Nephrologist Care in US Patients Approaching ESRD: Race, Age, and State Characteristics,” on pages 1979–1988.

  • Copyright © 2015 by the American Society of Nephrology

References

  1. ↵
    1. Obrador GT,
    2. Ruthazer R,
    3. Arora P,
    4. Kausz AT,
    5. Pereira BJ
    : Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 10: 1793–1800, 1999
    OpenUrlAbstract/FREE Full Text
    1. Kausz AT,
    2. Obrador GT,
    3. Arora P,
    4. Ruthazer R,
    5. Levey AS,
    6. Pereira BJ
    : Late initiation of dialysis among women and ethnic minorities in the United States. J Am Soc Nephrol 11: 2351–2357, 2000
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Hall YN,
    2. Sugihara JG,
    3. Go AS,
    4. Chertow GM
    : Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD. J Am Soc Nephrol 16: 3711–3720, 2005
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Kinchen KS,
    2. Sadler J,
    3. Fink N,
    4. Brookmeyer R,
    5. Klag MJ,
    6. Levey AS,
    7. Powe NR
    : The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 137: 479–486, 2002
    OpenUrlCrossRefPubMed
  4. ↵
    1. Arora P,
    2. Obrador GT,
    3. Ruthazer R,
    4. Kausz AT,
    5. Meyer KB,
    6. Jenuleson CS,
    7. Pereira BJ
    : Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol 10: 1281–1286, 1999
    OpenUrlAbstract/FREE Full Text
  5. ↵
    US Renal Data System: USRDS 2014 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2014. Available at: http://www.usrds.org/2014. Accessed August 8, 2015
  6. ↵
    1. Altman D,
    2. Frist WH
    : Medicare and Medicaid at 50 years: Perspectives of beneficiaries, health care professionals and institutions, and policy makers. JAMA 314: 384–395, 2015
    OpenUrlCrossRefPubMed
  7. ↵
    1. Carman KG,
    2. Eibner C,
    3. Paddock SM
    : Trends in health insurance enrollment, 2013-15. Health Aff (Millwood) 34: 1044–1048, 2015
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Yan G,
    2. Cheung AK,
    3. Greene T,
    4. Yu AJ,
    5. Olover MN,
    6. Yu W,
    7. Ma JZ,
    8. Norris KC
    : Interstate variation in receipt of nephrologist care in US patients approaching ESRD: Race, age, and state characteristics. Clin J Am Soc Nephrol 10: 1979–1988, 2015
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Prakash S,
    2. Rodriguez RA,
    3. Austin PC,
    4. Saskin R,
    5. Fernandez A,
    6. Moist LM,
    7. O’Hare AM
    : Racial composition of residential areas associates with access to pre-ESRD nephrology care. J Am Soc Nephrol 21: 1192–1199, 2010
    OpenUrlAbstract/FREE Full Text
    1. McClellan WM,
    2. Wasse H,
    3. McClellan AC,
    4. Kipp A,
    5. Waller LA,
    6. Rocco MV
    : Treatment center and geographic variability in pre-ESRD care associate with increased mortality. J Am Soc Nephrol 20: 1078–1085, 2009
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Kurella-Tamura M,
    2. Goldstein BA,
    3. Hall YN,
    4. Mitani AA,
    5. Winkelmayer WC
    : State medicaid coverage, ESRD incidence, and access to care. J Am Soc Nephrol 25: 1321–1329, 2014
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Hao H,
    2. Lovasik BP,
    3. Pastan SO,
    4. Chang HH,
    5. Chowdhury R,
    6. Patzer RE
    : Geographic variation and neighborhood factors are associated with low rates of pre-end-stage renal disease nephrology care. Kidney Int 88: 614–621, 2015
    OpenUrlCrossRefPubMed
  12. ↵
    1. Sommers BD,
    2. Gunja MZ,
    3. Finegold K,
    4. Musco T
    : Changes in self-reported insurance coverage, access to care, and health under the Affordable Care Act. JAMA 314: 366–374, 2015
    OpenUrlCrossRefPubMed
  13. ↵
    1. Hall YN,
    2. Choi AI,
    3. Chertow GM,
    4. Bindman AB
    : Chronic kidney disease in the urban poor. Clin J Am Soc Nephrol 5: 828–835, 2010
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Tuot DS,
    2. Grubbs V
    : Chronic kidney disease care in the US safety net. Adv Chronic Kidney Dis 22: 66–73, 2015
    OpenUrlCrossRefPubMed
  15. ↵
    1. Rocco P,
    2. Gellad WF,
    3. Donohue JM
    : Modernizing Medicaid managed care: Can states meet the data challenges? JAMA 2015: 1–3, 2015
    OpenUrl
  16. ↵
    1. Rodriguez RA,
    2. Sen S,
    3. Mehta K,
    4. Moody-Ayers S,
    5. Bacchetti P,
    6. O’Hare AM
    : Geography matters: Relationships among urban residential segregation, dialysis facilities, and patient outcomes. Ann Intern Med 146: 493–501, 2007
    OpenUrlCrossRefPubMed
    1. Tonelli M,
    2. Klarenbach S,
    3. Rose C,
    4. Wiebe N,
    5. Gill J
    : Access to kidney transplantation among remote- and rural-dwelling patients with kidney failure in the United States. JAMA 301: 1681–1690, 2009
    OpenUrlCrossRefPubMed
  17. ↵
    1. Patzer RE,
    2. Plantinga L,
    3. Krisher J,
    4. Pastan SO
    : Dialysis facility and network factors associated with low kidney transplantation rates among United States dialysis facilities. Am J Transplant 14: 1562–1572, 2014
    OpenUrlCrossRefPubMed
  18. ↵
    1. Graves JA,
    2. Swartz K
    : Understanding state variation in health insurance dynamics can help tailor enrollment strategies for ACA expansion. Health Aff (Millwood) 32: 1832–1840, 2013
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Baicker K,
    2. Taubman SL,
    3. Allen HL,
    4. Bernstein M,
    5. Gruber JH,
    6. Newhouse JP,
    7. Schneider EC,
    8. Wright BJ,
    9. Zaslavsky AM,
    10. Finkelstein AN,
    11. Carlson M,
    12. Edlund T,
    13. Gallia C,
    14. Smith J
    ; Oregon Health Study Group: The Oregon experiment--effects of Medicaid on clinical outcomes. N Engl J Med 368: 1713–1722, 2013
    OpenUrlCrossRefPubMed
  20. ↵
    1. Narva AS,
    2. Sequist TD
    : Reducing health disparities in American Indians with chronic kidney disease. Semin Nephrol 30: 19–25, 2010
    OpenUrlCrossRefPubMed
  21. ↵
    1. Goodell S,
    2. Sparer M
    : Medicaid Managed Care: Costs, Access and Quality of Care. Robert Wood Johnson Foundation. Available at: http://www.rwjf.org/content/dam/farm/reports/reports/2012/rwjf401106/subassets/rwjf401106_1. Accessed September 3, 2015
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology: 10 (11)
Clinical Journal of the American Society of Nephrology
Vol. 10, Issue 11
November 06, 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Border Health: State-Level Variation in Predialysis Nephrology Care
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Border Health: State-Level Variation in Predialysis Nephrology Care
Yoshio N. Hall, Jonathan Himmelfarb
CJASN Nov 2015, 10 (11) 1892-1894; DOI: 10.2215/CJN.09440915

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Border Health: State-Level Variation in Predialysis Nephrology Care
Yoshio N. Hall, Jonathan Himmelfarb
CJASN Nov 2015, 10 (11) 1892-1894; DOI: 10.2215/CJN.09440915
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Footnotes
    • References
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Time to Procurement and Post-Kidney Transplant Outcomes
  • Recurrent Hyperkalemia in Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Treatment
  • Postkidney Transplant Care and Health Outcomes of US Veterans
Show more Editorials

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • Interstate Variation in Receipt of Nephrologist Care in US Patients Approaching ESRD: Race, Age, and State Characteristics
  • PubMed
  • Google Scholar

Keywords

  • end-stage renal disease
  • United States Renal Data System
  • progression of chronic renal failure
  • ethnicity
  • clinical epidemiology
  • chronic kidney disease

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire